Start the treatment of Keratoconus by C3-R method with UV-X. We have treated HUNDREDS of patients suffering from dreaded corneal disease Keratoconus at CSLC and results are amazing..
It either stabilizes the progression of Keratoconus or it is completely cured. The success rate ranges between 92-95% at.
Early symptoms of Keratoconus are change in the spectacle power. When the disease progresses, vision deteriorates and may not improve with spectacles.
It also causes distortion in vision with multiple images, streaking and sensitivity to light.
Redness, watering and pain in the eye may also take place.
The methods include:
We have treated hundreds of patients having keratoconus by CXL method, its results are amazing. It stabilises the shape of cornea. During the treatment cornea is strengthened by treating it with injection Riboflavin and Ultra violet light which creates cross linking of corneal collagen fibres and increases its strength up to 300 %. When detected early enough CXL can arrest the progression of Keratoconus. Patient can retain good sight with glasses, contact lenses and can be even treated by PRK as well as INTACS implantation.
Treating keratoconus using C3-R is fast and safe. The procedure is done on an outpatient basis, with the entire process taking about an hour and a half.
This is a surgical treatment, which is reserved for advanced cases of Keratoconus, where the vision cannot be improved with glasses or contact lenses. Here the central portion of the cornea is removed and replaced with a donor cornea of similar size. Since there is high possibility of complications and graft rejection, the surgery is reserved for most advanced cases.
Previously hard contact lenses were used for Keratoconus.
Early Keratoconus can be managed by giving rigid contact lenses to the patient which correct the irregularity of the cornea and provide better quality of vision. However, the disadvantage of contact lenses is that, in severe cases, optimal fitting is not achieved and rigid lenses are more difficult to wear.